biotech

Ignite It
5 min read • September 30, 2024

Pesticide-Free Food Tastes Better—Wait Until You Try Clean Cannabis This Autumn

Ignite It
5 min read • September 23, 2024

‘DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands’ – Marijuana Moment

Ignite It
4 min read • September 11, 2024

Want Organic Cannabis? Operators Are Turning To This Tech To Save Millions And Get Certified

Ignite It
4 min read • September 6, 2024

Transforming A 5,000-Year-Old Craft: How Weed Companies Use Data To Make Hash Without Losing Its Art

Ignite It
5 min read • September 5, 2024

No Brand, No Problem: California Company Powers Top Weed Brands Behind The Scenes Via White-Labeling

Ignite It
2 min read • August 21, 2024

Village Farms And TILT Holdings: A Tale Of Two Cannabis Companies Facing Diverging Fortunes

Ignite It
11 min read • August 13, 2024

‘Trump Endorsing Florida Marijuana Legalization Initiative Would ‘Guarantee Victory,’ Top Ally Roger Stone Says’ – Marijuana Moment

Ignite It
8 min read • August 13, 2024

Chilecito: A Valley In The Andes That Defeated Mega-Mining And Embraced Sustainable Cannabis

Ignite It
7 min read • August 12, 2024

Think You Can Do It All? 20,000 Reasons Why Automation Outperforms A Broad Approach In Cannabis

Ignite It
4 min read • August 9, 2024

AI Technology Once Used In Cancer Research Now Develops ‘Plant Vaccines’ For Cannabis Viroids

Ignite It
6 min read • August 1, 2024

Cannabis In The Deep South: This Mississippi Company Delivers More Bud For The Buck To Medical Marijuana Patients

Ignite It
2 min read • July 30, 2024

180 Life Sciences Reports Positive Topline Results Of A Clinical Pharmacology Study Testing A New Solid Formulation Of CBD With Enhanced Oral Uptake; Twelve Volunteers Received All Three Formulations In A Crossover Randomized Trial

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.